FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      AbbVie Acquires Chinese Biopharma for $745 Million

      AbbVie has announced a significant acquisition, agreeing to purchase a Chinese biopharmaceutical company for $745 million. This move is part of a broader strategy within the pharmaceutical industry to replenish pipelines as companies face impending patent expirations.

      The acquisition highlights AbbVie's commitment to expanding its portfolio, particularly in the area of pain management. The deal reflects a growing trend among pharmaceutical firms to secure innovative therapies that can sustain revenue streams in a competitive market.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud